HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

MDT

Medtronic plc (S&P 500)

Healthcare — Medical Devices

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Buy 1.8 / 5 24 analysts
$86.44
+$0.15 (+0.17%)
Target: $104.83 (21.3%)

Price History

52-Week Range
Sign in to add MDT to a watchlist or set price alerts.

Fundamentals

Market Cap$110.57B
P/E Ratio (TTM)21.29
Forward P/E13.49
EPS (TTM)$4.06
Dividend Yield3.34%
Profit Margin13.93%
Revenue Growth13.70%
ROE10.65%
Debt/Equity55.37
Recommendation Buy 1.8
Analyst Target$104.83
Analysts24
Next Earnings Sep 1, 2026 BMO
Indexes S&P 500

Technical Indicators

RSI (14)32.4
Beta0.57
SMA 20$90.87
SMA 40$90.95
52-Week High$106.33
52-Week Low$73.31
50-Day Avg$89.74
200-Day Avg$88.78
Avg Volume$8.80M
Volume$28.59M

Performance Analysis

NEUTRAL

MDT presents a mixed picture with both positive and negative indicators.

~ Trading at 40% of its 52-week range.
~ RSI at 32.4 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
~ Modest revenue growth of 13.7% year-over-year.
+ Wall Street consensus is "Buy" from 24 analysts.
+ Average analyst target of $104.83 implies 21.3% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Oct 01, 2026 21:01 UTC

Back to Screener Export Report